APA (7th ed.) Citation

Takaba, M., Nakano, K., Yoda, A., Otsuki, Y., Fujisawa, S., & Sen, K. (2025). Effective Management of Refractory Paraneoplastic Vasculitis in Myelodysplastic Syndromes With Azacitidine, Prednisolone, and Azathioprine. Case Reports in Hematology, 1. https://doi.org/10.1155/crh/5914934

Chicago Style (17th ed.) Citation

Takaba, Masamitsu, Kotaro Nakano, Akari Yoda, Yoshiro Otsuki, Shinya Fujisawa, and Kalyani Sen. "Effective Management of Refractory Paraneoplastic Vasculitis in Myelodysplastic Syndromes With Azacitidine, Prednisolone, and Azathioprine." Case Reports in Hematology 2025: 1. https://doi.org/10.1155/crh/5914934.

MLA (9th ed.) Citation

Takaba, Masamitsu, et al. "Effective Management of Refractory Paraneoplastic Vasculitis in Myelodysplastic Syndromes With Azacitidine, Prednisolone, and Azathioprine." Case Reports in Hematology, 2025, p. 1, https://doi.org/10.1155/crh/5914934.